Literature DB >> 28049656

HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.

R Kannan Mutharasan1, C Shad Thaxton2, Jarett Berry3, Martha L Daviglus4, Chun Yuan5, Jie Sun5, Colby Ayers3, Donald M Lloyd-Jones6, John T Wilkins7.   

Abstract

HDL efflux capacity and HDL particle size are associated with atherosclerotic CVD (ASCVD) events in middle-aged individuals; however, it is unclear whether these associations are present in older adults. We sampled 402 Chicago Healthy Aging Study participants who underwent a dedicated carotid MRI assessment for lipid-rich necrotic core (LRNC) plaque. We measured HDL particle size, HDL particle number, and LDL particle number with NMR spectroscopy, as well as HDL efflux capacity. We quantified the associations between HDL particle size and HDL efflux using adjusted linear regression models. We quantified associations between the presence of LRNC and HDL and LDL particle number, HDL particle size, and HDL efflux capacity using adjusted logistic regression models. HDL efflux capacity was directly associated with large (β = 0.037, P < 0.001) and medium (β = 0.0065, P = 0.002) HDL particle concentration and inversely associated with small (β = -0.0049, P = 0.018) HDL particle concentration in multivariable adjusted models. HDL efflux capacity and HDL particle number were inversely associated with prevalent LRNC plaque in unadjusted models (odds ratio: 0.5; 95% confidence interval: 0.26, 0.96), but not after multivariable adjustment. HDL particle size was not associated with prevalent LRNC. HDL particle size was significantly associated with HDL efflux capacity, suggesting that differences in HDL efflux capacity may be due to structural differences in HDL particles. Future research is needed to determine whether HDL efflux is a marker of ASCVD risk in older populations.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  high density lipoprotein/structure; lipid/efflux; low density lipoprotein

Mesh:

Substances:

Year:  2017        PMID: 28049656      PMCID: PMC5335590          DOI: 10.1194/jlr.P069039

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol.

Authors:  Sandhya Sankaranarayanan; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; Bela F Asztalos; Robert Bittman; George H Rothblat
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

Review 2.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

3.  Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease.

Authors:  Lin T Guey; Clive R Pullinger; Brian Y Ishida; Patricia M O'Connor; Christian Zellner; Omar L Francone; Jason M Laramie; Josefina M Naya-Vigne; Ketevan A Siradze; Prakash Deedwania; Rita F Redberg; Philip H Frost; Albert B Seymour; John P Kane; Mary J Malloy
Journal:  Am J Cardiol       Date:  2011-08-01       Impact factor: 2.778

4.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

5.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

6.  Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects.

Authors:  Rindert de Vries; Frank G Perton; Arie van Tol; Robin P F Dullaart
Journal:  Clin Chim Acta       Date:  2011-11-11       Impact factor: 3.786

7.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

8.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

9.  Magnetic resonance imaging of carotid atherosclerosis: plaque analysis.

Authors:  William Kerwin; Dongxiang Xu; Fei Liu; Tobias Saam; Hunter Underhill; Norihide Takaya; Baocheng Chu; Thomas Hatsukami; Chun Yuan
Journal:  Top Magn Reson Imaging       Date:  2007-10

10.  Carotid magnetic resonance imaging for monitoring atherosclerotic plaque progression: a multicenter reproducibility study.

Authors:  Jie Sun; Xue-Qiao Zhao; Niranjan Balu; Daniel S Hippe; Thomas S Hatsukami; Daniel A Isquith; Kiyofumi Yamada; Moni B Neradilek; Gádor Cantón; Yunjing Xue; Jerome L Fleg; Patrice Desvigne-Nickens; Michael T Klimas; Robert J Padley; Maria T Vassileva; Bradley T Wyman; Chun Yuan
Journal:  Int J Cardiovasc Imaging       Date:  2014-09-13       Impact factor: 2.357

View more
  28 in total

1.  Metabolic syndrome is associated with increased risk of short-term post-procedural complications after carotid artery stenting.

Authors:  Shuyang Dong; Zeyan Peng; Yong Tao; Yinchao Huo; Huadong Zhou
Journal:  Neurol Sci       Date:  2017-08-07       Impact factor: 3.307

2.  Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians.

Authors:  Francesca Zimetti; Wladimir M Freitas; Alessandra M Campos; Mauricio Daher; Maria Pia Adorni; Franco Bernini; Andrei C Sposito; Ilaria Zanotti
Journal:  J Lipid Res       Date:  2018-02-07       Impact factor: 5.922

3.  Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer.

Authors:  Sara Fernández-Castillejo; Laura Rubió; Álvaro Hernáez; Úrsula Catalán; Anna Pedret; Rosa-M Valls; Juana I Mosele; Maria-Isabel Covas; Alan T Remaley; Olga Castañer; Maria-José Motilva; Rosa Solá
Journal:  Mol Nutr Food Res       Date:  2017-10-26       Impact factor: 5.914

4.  High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.

Authors:  Tatjana Josefs; Kristiaan Wouters; Uwe J F Tietge; Wijtske Annema; Robin P F Dullaart; Tomas Vaisar; Ilja C W Arts; Carla J H van der Kallen; Coen D A Stehouwer; Casper G Schalkwijk; Ira J Goldberg; Edward A Fisher; Marleen M J van Greevenbroek
Journal:  J Clin Lipidol       Date:  2019-10-31       Impact factor: 4.766

5.  A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity.

Authors:  Henrique Dos Santos Seckler; Luca Fornelli; R Kannan Mutharasan; C Shad Thaxton; Ryan Fellers; Martha Daviglus; Allan Sniderman; Daniel Rader; Neil L Kelleher; Donald M Lloyd-Jones; Philip D Compton; John T Wilkins
Journal:  J Proteome Res       Date:  2018-04-27       Impact factor: 4.466

Review 6.  Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.

Authors:  Annabelle Rodriguez; Bernardo L Trigatti; Chieko Mineo; Darcy Knaack; John T Wilkins; Daisy Sahoo; Bela F Asztalos; Samia Mora; Marina Cuchel; Henry J Pownall; Corina Rosales; Pascal Bernatchez; Amanda Ribeiro Martins da Silva; Godfrey S Getz; Jacob L Barber; Gregory C Shearer; Angela M Zivkovic; Uwe J F Tietge; Frank M Sacks; Margery A Connelly; Michael N Oda; W Sean Davidson; Mary G Sorci-Thomas; Tomas Vaisar; Giacomo Ruotolo; Kasey C Vickers; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-10       Impact factor: 8.311

7.  HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.

Authors:  Mohamad O Ahmed; Rachel E Byrne; Agnieszka Pazderska; Ricardo Segurado; Weili Guo; Anjuli Gunness; Isolda Frizelle; Mark Sherlock; Khalid S Ahmed; Anne McGowan; Kevin Moore; Gerard Boran; Fiona C McGillicuddy; James Gibney
Journal:  Diabetologia       Date:  2020-11-09       Impact factor: 10.122

Review 8.  High-density lipoproteins, reverse cholesterol transport and atherogenesis.

Authors:  Henry J Pownall; Corina Rosales; Baiba K Gillard; Antonio M Gotto
Journal:  Nat Rev Cardiol       Date:  2021-04-08       Impact factor: 32.419

9.  HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study.

Authors:  Sara Sokooti; Jose L Flores-Guerrero; Lyanne M Kieneker; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

10.  Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Parveen K Garg; Neal W Jorgensen; Robyn L McClelland; Matthew Allison; James H Stein; Laurent Yvan-Chavret; Alan R Tall; Steven Shea
Journal:  Atherosclerosis       Date:  2020-02-15       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.